GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma

• 主要な著者: Shiwen Ma (著者), Fei Xie (著者), Xiaohu Wen (著者), Yao Mawulikplimi Adzavon (著者), Ruping Zhao (著者), Jinyi Zhao (著者), Han Li (著者), Yanqi Li (著者), Jingtao Liu (著者), Chen Liu (著者), Yang Yi (著者), Pengxiang Zhao (著者), Boqing Wang (著者), Wei Zhao (著者), Xuemei Ma (著者)
• フォーマット: 図書
• 出版事項: Elsevier, 2024-12-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

The emergence of sorafenib resistance has become a predominant impediment and formidable dilemma in the therapeutic approach for hepatocellular carcinoma (HCC). Although the approval of next-generation drugs as alternatives to sorafenib is a significant development, the concurrent use of inhibitors...